Cellcept and Nail abnormalities - a phase IV clinical study of FDA data

Summary:

Nail abnormalities is reported only by a few people who take Cellcept.

The phase IV clinical study analyzes which people take Cellcept and have Nail abnormalities. It is created by eHealthMe based on reports of 37,071 people who have side effects while taking Cellcept from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 01, 2023

37,071 people reported to have side effects when taking Cellcept.
Among them, 2 people (0.01%) have Nail abnormalities.

What is Cellcept?

Cellcept has active ingredients of mycophenolate mofetil. It is often used in systemic lupus erythematosus. eHealthMe is studying from 37,843 Cellcept users for its effectiveness, alternative drugs and more.

What is Nail abnormalities?

Nail abnormalities (abnormal nail) is found to be associated with 902 drugs and 614 conditions by eHealthMe.

Number of Cellcept and Nail abnormalities reports submitted per year:

Could Cellcept cause Nail abnormalities?

Gender of people who have Nail abnormalities when taking Cellcept *:

female: 0.0 %
male: 100 %

Age of people who have Nail abnormalities when taking Cellcept *:

Common drugs people take besides Cellcept *:

Xeloda: 1 person, 50.00%
Thalidomide: 1 person, 50.00%
Tacrolimus: 1 person, 50.00%
Prograf: 1 person, 50.00%

Common side effects people have besides Nail abnormalities *:

White Blood Cell Count Decreased: 1 person, 50.00%
Skin Fissures (a crack in the skin): 1 person, 50.00%
Skin Exfoliation (removal of the oldest dead skin cells): 1 person, 50.00%
Skin Discoloration: 1 person, 50.00%
Nasal Dryness (dry nose): 1 person, 50.00%
Localised Infection (infection at the single location): 1 person, 50.00%
Dry Skin: 1 person, 50.00%
Dry Mouth: 1 person, 50.00%
Dactylitis (dactylitis or sausage digit is inflammation of an entire digit (a finger or toe), and can be painful): 1 person, 50.00%
Blood Bilirubin Increased: 1 person, 50.00%

* Approximation only. Some reports may have incomplete information.

Do you take Cellcept and have Nail abnormalities?

Check whether Nail abnormalities is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Nail abnormalities and when was it recovered:

Nail abnormalities in Cellcept

Expand to all the drugs that have ingredients of mycophenolate mofetil:

Nail abnormalities and drugs with ingredients of mycophenolate mofetil (4 reports)

Alternative drugs to, pros and cons of Cellcept:

Cellcept (37,843 reports)

Common Cellcept side effects:

Diarrhea: 2,176 reports
Fever: 1,957 reports
Pneumonia: 1,631 reports
Breathing difficulty: 1,619 reports
Drug ineffective: 1,585 reports
Fatigue (feeling of tiredness): 1,555 reports
Death: 1,454 reports
Weakness: 1,407 reports

Browse all side effects of Cellcept:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Nail abnormalities treatments and more:

Nail abnormalities (1,978 reports)

COVID vaccines that are related to Nail abnormalities:

Common drugs associated with Nail abnormalities:

Docetaxel: 149 reports
Paclitaxel: 149 reports

How the study uses the data?

The study uses data from the FDA. It is based on mycophenolate mofetil (the active ingredients of Cellcept) and Cellcept (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.